COVID-19 vaccines need novel approaches to ensure best balance of safety and efficacy: GlobalData EP News Bureau Aug 26, 2020 AstraZeneca’s AZD-1222 and Moderna’s mRNA-1273 are currently the most promising vaccine candidates, it states
